HTG Molecular Diagnostics

HTG Molecular Diagnostics, Inc. engages in the provision of molecular technology solutions that facilitates molecular profiling. It serves the biopharmaceutical companies, academic research centres, and molecular testing laboratories. Its proprietary HTG EdgeSeq technology automates complex, highly multiplexed molecular profiling from solid and liquid samples, even when limited in amount. The company was founded by Bruce E. Seligmann in October 1997 and is headquartered in Tucson, AZ.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

HTG Molecular Diagnostics, Inc. (HTGM) CEO John Lubniewski on Q2 2019 Results - Earnings Call Transcript

HTG Molecular Diagnostics, Inc. (HTGM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report.

Analysts Estimate HTG Molecular Diagnostics, Inc. (HTGM) to Report a Decline in Earnings: What to Look Out for

HTG Molecular Diagnostics, Inc. (HTGM) CEO John Lubniewski on Q1 2019 Results - Earnings Call Transcript

HTG Molecular Diagnostics, Inc. (HTGM) delivered earnings and revenue surprises of -11.76% and 15.84%, respectively, for the quarter ended March 2019.

HTG Molecular Diagnostics, Inc. (HTGM) Reports Q1 Loss, Tops Revenue Estimates

News for HTG Molecular Diagnostics Stock (HTGM)